Cargando…

Frontiers in antiviral therapy and immunotherapy

Detalles Bibliográficos
Autor principal: Heaton, Steven M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030942/
https://www.ncbi.nlm.nih.gov/pubmed/32099652
http://dx.doi.org/10.1002/cti2.1115
_version_ 1783499279332016128
author Heaton, Steven M
author_facet Heaton, Steven M
author_sort Heaton, Steven M
collection PubMed
description
format Online
Article
Text
id pubmed-7030942
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70309422020-02-25 Frontiers in antiviral therapy and immunotherapy Heaton, Steven M Clin Transl Immunology Special Feature Editorial John Wiley and Sons Inc. 2020-02-19 /pmc/articles/PMC7030942/ /pubmed/32099652 http://dx.doi.org/10.1002/cti2.1115 Text en © 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Feature Editorial
Heaton, Steven M
Frontiers in antiviral therapy and immunotherapy
title Frontiers in antiviral therapy and immunotherapy
title_full Frontiers in antiviral therapy and immunotherapy
title_fullStr Frontiers in antiviral therapy and immunotherapy
title_full_unstemmed Frontiers in antiviral therapy and immunotherapy
title_short Frontiers in antiviral therapy and immunotherapy
title_sort frontiers in antiviral therapy and immunotherapy
topic Special Feature Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030942/
https://www.ncbi.nlm.nih.gov/pubmed/32099652
http://dx.doi.org/10.1002/cti2.1115
work_keys_str_mv AT heatonstevenm frontiersinantiviraltherapyandimmunotherapy